Quickfind
Show latest about:
Sector
Topic
Keep settings
  Freetext search
 Home
 News
 Analysis
 Features
 Market prices
 Technology guide
 Real estate
 Israel in depth
RSS  feeds
  Search results
News
Teva stands to lose if Mylan slides further
Teva has so far posted a $600 million loss on its 5% holding in Mylan.
Aviv Levy   29 Aug 16   18:31

US board invalidates Copaxone double-dose patents
Israeli company Teva Pharmaceutical Industries says it will appeal the decision.
Globes correspondent   25 Aug 16   09:22

Pfizer's acquisition of Medivation lifts Clal Biotech
Medivation has signed an agreement to buy an anti-cancer drug being developed by Clal Biotech-controlled CureTech.
Kobi Yeshayahou   23 Aug 16   22:03

Belgian co invests in proton therapy co HIL
Belgium's Ion Beam Applications S.A. has also signed an OEM agreement with Jerusalem-based HIL Applied Medical.
Globes correspondent   23 Aug 16   09:40

FDA decision boosts Beta-02's artificial pancreas
Gali Weinreb   22 Aug 16   19:02

Teva awaits fateful Copaxone patents decisions
Shiri Habib-Valdhorn   21 Aug 16   16:21

US co SeaSpine buys Israel's NLT Spine
Gali Weinreb   21 Aug 16   10:57

Features
Alfred Mann's legacy stimulates Israeli innovation
David Hankin, who heads the Mann foundations, talks to "Globes" about what they can do that established medical device companies can't or won't.
Gali Weinreb   25 Aug 16   20:59

Japanese drug co Takeda seeks investments in Israel
Takeda Pharmaceuticals is looking for startups dealing with diagnostics and digital technologies.
Gali Weinreb   24 Aug 16   13:29

"Expect Israeli IPOs in New York soon"
William Blair managing director Steve Maletzky visited Israel to meet local companies with Wall Street aspirations, and talked to "Globes". 
Shiri Habib-Valdhorn   23 Aug 16   11:58

Making Israel a global hub for brain technologies
Globes correspondent   10 Aug 16   13:17

Rosario capital sees RedHill breakthrough
Zeev Zak   12 Jul 16   16:23

"Our triangular implant leaves more room for bone"
Gali Weinreb   28 Jun 16   19:25

Steba offers prostate cancer patients a better approach
Gali Weinreb   20 Jun 16   15:03

Teva stands behind Allergan price
Shiri Habib-Valdhorn    9 Jun 16   19:02

Israeli co brings gynecology into the 21st century
Gali Weinreb    9 Jun 16   10:37

"Our investors are aware of Israeli capabilities"
Gali Weinreb   24 May 16   14:26

New Kamada CEO optimistic despite European setback
Gali Weinreb    5 May 16   07:55

Pharma team seeks Israeli technologies
Gali Weinreb    3 May 16   18:46

Drug cos funding for Israeli hospital research soars
Shay Niv   20 Apr 16   15:34